1
CNS Conferences 2026
Updated 11FEB2026
Month
Conference
January
American College of
Neuropsychopharmaco
logy
Dates
(2026)
January
Location
Relevant Specialties /
Indications
Bahamas
scientific program in clinical
and basic research on brain
behavior-drug interactions;
12-15
Psychopharmacology,
depression, bipolar, anxiety,
ADHD, SUD
February
International Stroke
Conference (AHA/ASA)
Feb
SCOPE Summit
Feb
4–6
New
Orleans,
Louisiana
Stroke, cerebrovascular
disease, neurocritical care
Orlando, FL
Clinical trials operations,
digital health, CNS study
design, data strategy
Las Vegas,
NV
largest and most
comprehensive conference on
the psychopharmacological
treatment of psychiatric
disorders
Washington,
DC
CNS endpoints, rater training,
scale methodology,
schizophrenia, depression,
ADHD, dementia, bipolar,
neurodegeneration
10–13
Nevada Psychiatric
Association's (NPA)
Annual National
Psychopharmacology
Update
ISCTM – Intl. Society
for CNS Clinical Trials
& Methodology
Psychedelic
Therapeutics & Drug
Development
Conference
Feb
11-14
Feb
18-20
FEB
26-27
New
Orleans, LA
Accellacare CNS Initiative — Oversight and Documentation Record
Prepared by: Angel Motto — CNS Learning Initiative Strategy & Planning- CNS Focus Group
2
March
International Society
for Research on
Psychedelics
Feb 27-
World Neuroscience &
Psychiatry Conference
Mar
Cognitive
Neuroscience Society
(CNS) Annual Meeting
Mar
CNS Disorders &
Therapeutics Summit
AD/PD – Alzheimer’s &
Parkinson’s Diseases
Conference
April
May
WCG MAGI Clinical
Research Conference
Mar 1
6–7
7–10
Mar
10–11
Mar
17–26
April
provide scientific networking
and advancement of empirical
science regarding classic
psychedelics
Bangkok,
Thailand
General neuroscience,
psychiatry, anxiety, mood
disorders
Vancouver,
Canada
Cognitive function, memory,
attention, neuroimaging,
neuropsychology
Amsterdam,
Netherlands
CNS drug development,
neuroinflammation, psychiatric
disorders
Copenhagen
, Denmark
Alzheimer’s, Parkinson’s,
Lewy body dementia, MCI,
neurodegeneration
Chicago, IL
Clinical trial operations, CNS
site readiness, regulatory,
monitoring
San Diego,
CA
The Social & Affective
Neuroscience Society (SANS)
is committed to research
investigating the neural basis
of social and affective
processes.
Chicago, IL
All neurology: MS, epilepsy,
neuropathies, ALS, stroke,
movement disorders
New York
City, New
York
focuses on alternative and
transformative frameworks for
understanding psychiatric
illnesses and the use of
enhanced and newly
emerging tools for
experimental measurement
and manipulation.
12-15
SANS
April
Social and Affective
Neuroscience
Society
15-18
American Academy of
Neurology (AAN)
Annual Meeting
Apr
Society of Biological
Psychiatry (SOBP)
Annual Meeting
New
Orleans, LA
18-22
April 30–
May 02
Accellacare CNS Initiative — Oversight and Documentation Record
Prepared by: Angel Motto — CNS Learning Initiative Strategy & Planning- CNS Focus Group
3
American Psychiatric
Association APA
Annual Meeting
World Parkinson's
Congress
American Society of
Clinical
Psychopharmacology
(ASCP) Annual
Meeting
June
May
16–20
May
May
ICPR
Interdisciplinary
Conference on
Psychedelic
Research
Jun
Drug Information
Association (DIA)
Global Annual Meeting
Jun
European Academy of
Neurology (EAN)
Congress
Phoenix, AZ
Miami, FL
26-29
Jun
The International
College of
Neuropsychopharmaco
logy (CINP)
Depression, bipolar, anxiety,
schizophrenia, OCD, PTSD,
SUD
24-27
The Society for Clinical
Research Sites
FIN-2026: Frontiers in
Neurosciences
San
Francisco,
CA
1-2
Scottsdale,
AZ
Netherlands
At ICPR, science, practice,
and policy meet: intellectual
rigor, cutting-edge evidence,
and meaningful discussions
on the real-world applications
of psychedelics.
Philadelphia,
PA
Clinical development,
regulatory, drug safety, CNS
trials
Prague,
Czech
Republic
Neurology, neurobiology,
neurodevelopment
Glasgow,
Scotland
Advancing worldwide
neuroscience and education
for brain and mental health
Geneva
Europe-wide neurology:
stroke, MS, epilepsy,
headache, dementia
4-6
14–18
Jun
18–19
Jun
26-29
Jun 27–30
key aspects of
neuropsychiatric drug
development, including the
impact of diagnostic changes
and personalized interventions
based on biomarkers or
genetic information
Accellacare CNS Initiative — Oversight and Documentation Record
Prepared by: Angel Motto — CNS Learning Initiative Strategy & Planning- CNS Focus Group
4
July
Alzheimer’s
Association
International
Conference (AAIC)
Jul 12–15
London, UK
Alzheimer’s, MCI, dementia,
biomarker development
September
Psych Congress
September
15-19
New
Orleans, LA
Psychiatry: mood disorders,
trauma, anxiety, SUD,
psychopharmacology
Neurology World
Conference (NWC)
Sep 18–20
Miami, FL
General neurology, global
CNS disease trends
CNS Summit
NOV
Boston, MA
clinical development and
commercialization, healthcare
innovation and regulatory
authorities, patient advocates,
investors
Milan, Italy
Parkinson’s, dystonia, atypical
parkinsonism, movement
disorders
Boston, MA
Alzheimer’s, dementia,
amyloid/tau therapies,
caregiver outcomes
TBA
emergency mental health
October
November
1-4
World Congress on
Parkinson’s Disease &
Related Disorders
(IAPRD)
CTAD – Clinical Trials
on Alzheimer’s Disease
December
The American
Association for
Emergency Psychiatry
(AAEP)
NOV
11-14
Nov
16-19
DEC TBA
Accellacare CNS Initiative — Oversight and Documentation Record
Prepared by: Angel Motto — CNS Learning Initiative Strategy & Planning- CNS Focus Group